The FDA announced it has approved the use of two color additives from natural sources in over a dozen foods and beverages while expanding the approval of another. According to a press release ...

In its 15th year, Verastem Oncology has gained its first FDA approval, winning an accelerated nod for the combination treatment of avutometinib and defactinib for a rare form of ovarian cancer.

Friday's approval expands its use for coloring ready-to-eat cereal, crackers, snack mixes and some chips. The FDA also approved calcium phosphate, which imparts a white color, for use in ready-to ...

This approval marks a historic moment for the EB community as the third FDA approved treatment and the first autologous, cell-based gene therapy for RDEB (Recessive Dystrophic Epidermolysis Bullosa).